Navigation Links
Tiagabine Enhances Sleep Maintenance In Insomnia Patients

Recent research indicates that tiagabine, a selective ?-aminobutyric acid (GABA) reuptake inhibitor, has positive effect on sleep and next-morning alertness and performance in adult patients with primary insomnia.//

Primary insomnia is characterized by difficulty initiating or maintaining sleep and/or nonrestorative sleep, which causes clinically significant distress or impairment in important areas of waking function.

The authors, writing in the journal Sleep Medicine (available online 2 November 2005) assert that since GABA is a major inhibitory neurotransmitter in the central nervous system and tiagabine increases synaptic availability of GABA, hypnotic properties would seem a likely dose-related effect.

The researchers evaluated the effect of tiagabine administered before bedtime at doses from 4 to 16 mg on sleep and next-morning alertness and psychomotor performance in adult patients with primary insomnia.

Fifty-eight middle-aged patients were randomized for the study. Results showed a significant dose-dependent increase in slow wave sleep percentage with all tiagabine doses, a trend toward a dose-dependent increase in total sleep time, and no effect on latency to persistent sleep.

The authors conclude that tiagabine increased slow wave sleep and reduced wake after sleep onset in a dose-dependent manner. Tiagabine dosages up to 8 mg did not compromise next-morning alertness and psychomotor performance in adult patients with primary insomnia. Further investigation of tiagabine doses up to 8 mg is warranted.

The authors suggest that additional studies with tiagabine are warranted to further investigate tiagabine's clinical effects in patients with insomnia. Also of interest are the potential differences associated with increases in slow wave sleep mediated by different neurotransmitter systems.


'"/>




Page: 1

Related medicine news :

1. Animal Fat Enhances Risk Of Stomach
2. Simulated Heart Tissue Enhances Understanding of Arrhythmias And Defibrillator Failure
3. Glivec Enhances Survival Rates In Leukemia
4. Study Claims That Chemo Before And After Surgery Enhances Survival Rates
5. Common Virus Enhances Cancer-Fighting Ability of Standard Chemotherapy Drugs
6. Haryana Enhances Nutritional Support for Women, Children
7. Loop Incision Treatment Enhances Premature Delivery Risk
8. Sleep apnoea increases post-operative risks
9. Sleep, snoring....stroke
10. Sleeping sickness - a silent killer
11. Deep Sleep Doesnt Increase Memory
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... March 23, 2017 , ... GeBBS Healthcare Solutions unveils ... HCCA’s 21st annual Compliance Institute on March 26-28 in National Harbor, Maryland. ... medical chart types with a comprehensive set of features including built-in workflow, interactive ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... “Wounded Woman ... “Wounded Woman Be Ye Healed-Passing On A Legacy” is the creation of published author, ... founder of Comfortbearers grief ministry. She has been happily married to her husband, ...
(Date:3/23/2017)... ... March 23, 2017 , ... “A Respectful Response To Atheist ... To Atheist Manifesto” is the creation of published author Richard Hostetter, a former ... years. He holds graduate degrees from Kent State University and the University of ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... today announced the publication of “Profiling protein expression in circulating tumor cells using ... publication describes the use of the Vortex technology to capture CTCs ...
(Date:3/22/2017)... ... March 23, 2017 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... Convention, currently taking place at the Suntec Singapore International Exhibition & Convention Centre, ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... Research and Markets has announced the addition of the ... Insight 2022" drug pipelines to their offering. ... Global Immune ... gives comprehensive insight on clinical and non-clinical aspects involved in ... main streamline drugs in the immunotherapy treatment. Report helps to ...
(Date:3/22/2017)... Mar 22, 2017 Research and Markets has ... & Trends - Industry Forecast to 2025" report to their ... The ... of around 7.1% over the next decade to reach approximately $129.81 ... estimates and forecasts for all the given segments on global as ...
(Date:3/22/2017)... , March 22, 2017  Applied BioMath ( ... to drug research and development, today announced the ... QSP Day 2017 is a day full of ... systems pharmacology (QSP) community. The focus is to ... de-risking and accelerating drug research and development. ...
Breaking Medicine Technology: